Search for Specific Inhibitors Targeting Type IA Topoisomerases

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• Type IA topoisomerases, including bacterial topoisomerase I and III, and eukaryotic topoisomerase III, are essential enzymes.
• These enzymes play critical roles in DNA topology, with implications in neurological development (human TOP3B), cancer, and infectious diseases.

Purpose of the Study:

• To highlight type IA topoisomerases as novel targets for therapeutic intervention.
• To review current strategies and challenges in developing small molecule inhibitors for these enzymes.

Main Methods:

• Computational approaches like docking and machine learning.
• High-throughput screening (HTS) including enzyme-based and cell-based assays.
• Analysis of existing literature on type IA topoisomerase inhibitors.

Main Results:

• Identified type IA topoisomerases as potential targets for antibacterial, anticancer, antiviral, and antiparasitic agents.
• Screening campaigns have yielded compounds that inhibit catalytic activity or trap covalent complexes.
• Existing small molecule inhibitors for bacterial topoisomerase I and human TOP3B show insufficient potency and selectivity.

Conclusions:

• Type IA topoisomerases represent promising targets for novel therapeutics.
• Overcoming challenges like lack of structural data and target validation is crucial for developing effective inhibitors.
• Integrated virtual and experimental screening approaches are recommended for future drug discovery efforts.